Skip to content

Clinical trials

Phase 1/2 Carcinoma, Ovarian Epithelial trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 1/2 Country / region: Denmark Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20121
20171
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vejle Hospital2
Amgen1
Novakand Pharma AB1
Pfizer1
Valerio Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial6
Ovarian Neoplasms4
Fallopian Tube Neoplasms2
Recurrence2
Adenocarcinoma of Lung1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Cholangiocarcinoma1
Squamous Cell Carcinoma of Head and Neck1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.